Company Filing History:
3 out of 18 
3 out of 1,309 
3 out of 1,210 
Years Active: 1995-2011
Title: Anthony Anisowicz: Innovator in Dkk Protein Research
Introduction
Anthony Anisowicz is a notable inventor based in West Newton, MA (US). He has made significant contributions to the field of biotechnology, particularly in the synthesis and purification of Dkk proteins. With a total of 6 patents to his name, Anisowicz has developed innovative methods that have implications in medical research and treatment.
Latest Patents
One of his latest patents is titled "Method of synthesizing and purifying Dkk proteins and Dkk proteins obtained thereby." This invention relates to a novel method for inexpensively synthesizing large quantities of essentially pure, biologically active, glycosylated Dkk proteins, including mammalian and human Dkk proteins such as human Dkk1. The invention also details the characteristics of the synthetically produced, essentially purified, glycosylated, and biologically active Dkk protein.
Another significant patent is "Reagents and method for modulating Dkk-mediated interactions." This invention provides reagents, compounds, compositions, and methods related to novel interactions of the extracellular domain of LRP5, HBM (a variant of LRP5), and/or LRP6 with Dkk, including Dkk-1. The various nucleic acids, polypeptides, antibodies, assay methods, diagnostic methods, and treatment methods described in this patent are crucial for modulating lipid levels and bone mass, which are important in addressing disorders such as osteoporosis.
Career Highlights
Throughout his career, Anisowicz has worked with prominent companies in the pharmaceutical industry, including Oscient Pharmaceuticals Corporation and Wyeth. His work has focused on advancing the understanding of Dkk proteins and their role in cellular signaling.
Collaborations
Anisowicz has collaborated with notable colleagues such as Kristina Allen and Ruth Sager, contributing to the advancement of research in his field.
Conclusion
Anthony Anisowicz is a distinguished inventor whose work in Dkk protein research has the potential to impact medical treatments significantly. His innovative patents and collaborations highlight his commitment to advancing biotechnology.